Gil Blum
Stock Analyst at Needham
(4.67)
# 804
Out of 4,517 analysts
701
Total ratings
43.9%
Success rate
14.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELC Celcuity | Reiterated: Buy | $157 | $91.51 | +71.57% | 33 | Jul 15, 2026 | |
| FATE Fate Therapeutics | Maintained: Hold | $3.11 | $2.99 | +4.01% | 23 | Jul 10, 2026 | |
| NRIX Nurix Therapeutics | Maintained: Buy | $34 | $23.85 | +42.56% | 47 | Jul 10, 2026 | |
| TSHA Taysha Gene Therapies | Maintained: Buy | $12 | $6.19 | +93.86% | 49 | Jul 1, 2026 | |
| CRSP CRISPR Therapeutics AG | Maintained: Buy | $82 | $51.37 | +59.63% | 41 | Jun 24, 2026 | |
| ABSI Absci | Reiterated: Buy | $7 → $11 | $9.76 | +12.70% | 13 | Jun 24, 2026 | |
| TCRX TScan Therapeutics | Reiterated: Buy | $6 | $0.9231 | +549.98% | 17 | Jun 23, 2026 | |
| LYEL Lyell Immunopharma | Maintained: Buy | $44 | $14.26 | +208.56% | 5 | Jun 15, 2026 | |
| RNAC Cartesian Therapeutics | Reiterated: Buy | $40 | $8.68 | +360.83% | 36 | Jun 9, 2026 | |
| ARTV Artiva Biotherapeutics | Reiterated: Buy | $41 | $9.92 | +313.31% | 15 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $34.68 | +116.26% | 22 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $9.62 | +97.51% | 7 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $1.51 | +562.25% | 50 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $11 | $2.66 | +313.53% | 22 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $0.3279 | +814.91% | 34 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.65 | - | 49 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $17.61 | - | 55 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 | $3.31 | +141.69% | 29 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $1.42 | +181.69% | 35 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $6.77 | - | 28 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.85 | - | 25 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.63 | n/a | 15 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 400.00 → kr 371.00 | kr 184.00 | n/a | 16 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $32.50 | n/a | 14 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $102.07 | n/a | 10 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 6 | Jun 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.0001 | n/a | 5 | Apr 6, 2022 |
Celcuity
Jul 15, 2026
Reiterated: Buy
Price Target: $157
Current: $91.51
Upside: +71.57%
Fate Therapeutics
Jul 10, 2026
Maintained: Hold
Price Target: $3.11
Current: $2.99
Upside: +4.01%
Nurix Therapeutics
Jul 10, 2026
Maintained: Buy
Price Target: $34
Current: $23.85
Upside: +42.56%
Taysha Gene Therapies
Jul 1, 2026
Maintained: Buy
Price Target: $12
Current: $6.19
Upside: +93.86%
CRISPR Therapeutics AG
Jun 24, 2026
Maintained: Buy
Price Target: $82
Current: $51.37
Upside: +59.63%
Absci
Jun 24, 2026
Reiterated: Buy
Price Target: $7 → $11
Current: $9.76
Upside: +12.70%
TScan Therapeutics
Jun 23, 2026
Reiterated: Buy
Price Target: $6
Current: $0.9231
Upside: +549.98%
Lyell Immunopharma
Jun 15, 2026
Maintained: Buy
Price Target: $44
Current: $14.26
Upside: +208.56%
Cartesian Therapeutics
Jun 9, 2026
Reiterated: Buy
Price Target: $40
Current: $8.68
Upside: +360.83%
Artiva Biotherapeutics
Jun 8, 2026
Reiterated: Buy
Price Target: $41
Current: $9.92
Upside: +313.31%
Jun 1, 2026
Maintained: Buy
Price Target: $75
Current: $34.68
Upside: +116.26%
May 14, 2026
Reiterated: Buy
Price Target: $19
Current: $9.62
Upside: +97.51%
May 14, 2026
Maintained: Buy
Price Target: $10
Current: $1.51
Upside: +562.25%
May 13, 2026
Rated: Buy
Price Target: $11
Current: $2.66
Upside: +313.53%
May 12, 2026
Maintained: Buy
Price Target: $3
Current: $0.3279
Upside: +814.91%
May 8, 2026
Maintained: Hold
Price Target: n/a
Current: $3.65
Upside: -
May 7, 2026
Maintained: Sell
Price Target: n/a
Current: $17.61
Upside: -
May 7, 2026
Rated: Buy
Price Target: $8
Current: $3.31
Upside: +141.69%
May 6, 2026
Maintained: Buy
Price Target: $4
Current: $1.42
Upside: +181.69%
Nov 7, 2025
Maintained: Hold
Price Target: n/a
Current: $6.77
Upside: -
Oct 24, 2025
Rated: Hold
Price Target: n/a
Current: $1.85
Upside: -
Dec 27, 2024
Rated: Hold
Price Target: n/a
Current: $6.63
Upside: n/a
Feb 16, 2023
Reiterated: Buy
Price Target: kr 400.00 → kr 371.00
Current: kr 184.00
Upside: n/a
Dec 7, 2022
Maintained: Buy
Price Target: $6
Current: $32.50
Upside: n/a
Aug 25, 2022
Rated: Hold
Price Target: n/a
Current: $102.07
Upside: n/a
Jun 3, 2022
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Apr 6, 2022
Reiterated: Buy
Price Target: $6
Current: $0.0001
Upside: n/a